PML nuclear bodies and chromatin dynamics: catch me if you can!

A Corpet, C Kleijwegt, S Roubille, F Juillard… - Nucleic Acids …, 2020 - academic.oup.com
Eukaryotic cells compartmentalize their internal milieu in order to achieve specific reactions
in time and space. This organization in distinct compartments is essential to allow …

[HTML][HTML] The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review

M Gasparotto, C Franco, E Zanatta, A Ghirardello… - Autoimmunity …, 2023 - Elsevier
Idiopathic inflammatory myopathies (IIM), even though sharing common clinical
manifestations, are characterized by diversified molecular pathogenetic mechanisms which …

Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis

C Preuße, B Paesler, C Nelke, D Cengiz… - Acta …, 2022 - Springer
Abstract Anti-synthetase syndrome (ASyS)-associated myositis is a major subgroup of the
idiopathic inflammatory myopathies (IIM) and is characterized by disease chronicity with …

COVID-19 infection among autoimmune rheumatic disease patients: data from an observational study and literature review

AD Bakasis, CP Mavragani, KA Boki, AG Tzioufas… - Journal of …, 2021 - Elsevier
The impact of SARS-CoV-2 infection in patients with autoimmune/auto-inflammatory
rheumatic diseases (AARD) under immunomodulatory treatment has been a focus of interest …

Clinical aspects of janus kinase (JAK) inhibitors in the cardiovascular system in patients with rheumatoid arthritis

PJ Kotyla, MA Islam, M Engelmann - International journal of molecular …, 2020 - mdpi.com
Janus kinase (JAK) inhibitors, a novel class of targeted synthetic disease-modifying
antirheumatic drugs (DMARDs), have shown their safety and efficacy in rheumatoid arthritis …

Involvement of type I interferon signaling in muscle stem cell proliferation during dermatomyositis

L Gallay, C Fermon, L Lessard, M Weiss-Gayet, S Viel… - Neurology, 2022 - AAN Enterprises
Background and Objectives The idiopathic inflammatory myopathy dermatomyositis is an
acquired disease that involves muscle, lung, and skin impairments. Patients with …

Inflammatory myopathy following coronavirus disease 2019 vaccination: a systematic review

Y Ding, Y Ge - Frontiers in Public Health, 2022 - frontiersin.org
Introduction Reports of unexpected side effects have accompanied the vaccination of larger
proportions of the population against coronavirus disease 2019 (COVID-19), including a few …

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

MG Ll Wilkinson, CT Deakin, C Papadopoulou… - Pediatric …, 2021 - Springer
Abstract Juvenile Idiopathic Inflammatory Myopathies (IIM) are a group of rare diseases that
are heterogeneous in terms of pathology that can include proximal muscle weakness …

Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy

Z Zhang, W Tao, D Cheng, M Qin, J Fu… - Frontiers in …, 2023 - frontiersin.org
Background The coronavirus disease (COVID-19) pandemic is a serious threat to public
health worldwide. Growing evidence reveals that there are certain links between COVID-19 …

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies

M Graf, SL von Stuckrad, A Uruha, J Klotsche… - RMD open, 2022 - rmdopen.bmj.com
Objective To evaluate sialic acid binding Ig-like lectin 1 (SIGLEC1) expression on
monocytes by flow cytometry as a type I interferon biomarker in idiopathic inflammatory …